CLOV
Clover Health Investments, Corp. NASDAQ Listed Jun 12, 2020$2.81
Mkt Cap $1.4B
52w Low $1.58
52.8% of range
52w High $3.92
50d MA $2.10
200d MA $2.53
P/E (TTM)
-15.9x
EV/EBITDA
-13.6x
P/B
4.5x
Debt/Equity
0.0x
ROE
-26.5%
P/FCF
-17.6x
RSI (14)
—
ATR (14)
—
Beta
2.25
50d MA
$2.10
200d MA
$2.53
Avg Volume
6.0M
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
725 Cool Springs Blvd · Franklin, TN 37067 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 0.07 | 0.07 | +0.0% | 2.68 | +3.0% | +5.2% | — | — | — | — | — |
| Feb 26, 2026 | AMC | -0.10 | -0.05 | +51.0% | 2.15 | -4.2% | -2.8% | -2.4% | -2.0% | +8.0% | -4.2% | — |
| Nov 4, 2025 | AMC | 0.02 | -0.05 | -350.0% | 3.52 | -19.9% | -15.6% | -12.1% | +2.3% | -2.6% | -1.9% | — |
| Aug 5, 2025 | AMC | 0.03 | 0.03 | +0.0% | 2.85 | -18.2% | -20.7% | -2.2% | -1.4% | +13.3% | +1.2% | — |
| May 6, 2025 | AMC | -0.07 | 0.05 | +171.4% | 3.35 | +3.0% | +12.5% | -0.5% | -6.4% | -1.1% | -2.0% | — |
| Mar 11, 2025 | AMC | -0.07 | -0.04 | +42.9% | 3.36 | +3.9% | +7.4% | -4.2% | +5.8% | +1.1% | +3.0% | — |
| Feb 27, 2025 | AMC | -0.07 | -0.04 | +42.9% | 4.14 | -3.6% | -4.1% | -8.3% | +2.2% | +3.0% | -4.2% | — |
| Nov 6, 2024 | AMC | -0.01 | -0.02 | -50.3% | 4.35 | -10.6% | -15.6% | -7.1% | -2.3% | -2.4% | -2.8% | — |
| Aug 5, 2024 | AMC | -0.05 | 0.01 | +120.0% | 1.88 | +6.4% | -2.7% | -8.7% | +9.6% | +1.6% | +0.5% | — |
| May 7, 2024 | AMC | -0.07 | -0.05 | +28.6% | 0.74 | +19.5% | +17.6% | -0.8% | -5.0% | +11.2% | +11.9% | — |
| Mar 12, 2024 | AMC | -0.18 | -0.12 | +33.3% | 0.77 | +10.7% | +5.0% | -10.0% | +10.0% | -1.8% | +4.9% | — |
| Nov 6, 2023 | AMC | -0.10 | -0.09 | +10.0% | 1.13 | -15.3% | -18.2% | -2.4% | -2.1% | +2.3% | -0.4% | — |
| Aug 8, 2023 | AMC | -0.13 | -0.06 | +53.8% | 1.33 | +10.5% | +4.5% | -5.0% | +13.6% | +4.0% | -9.0% | — |
| May 9, 2023 | AMC | -0.19 | -0.15 | +21.1% | 0.93 | -0.4% | -1.3% | +3.6% | +2.6% | -0.3% | +3.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $1.89 | $1.91 | +1.1% | +0.0% | -2.1% | -1.6% | +0.0% | -1.1% |
| Mar 5 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $2.16 | $2.16 | +0.0% | -4.2% | -3.4% | +0.0% | -0.5% | +1.5% |
| Jan 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.54 | $2.50 | -1.6% | +2.0% | +1.2% | +2.3% | -3.4% | -3.9% |
| Nov 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.97 | $2.99 | +0.7% | -12.1% | +2.3% | -2.6% | -1.9% | -1.6% |
| Aug 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.26 | $2.29 | +1.3% | -2.2% | -1.4% | +13.3% | +1.2% | +4.8% |
| Aug 6 | UBS | Maintains | Neutral → Neutral | — | $2.85 | $2.33 | -18.2% | -20.7% | -2.2% | -1.4% | +13.3% | +1.2% |
| Mar 3 | Canaccord Genuity | Maintains | Buy → Buy | — | $3.97 | $3.96 | -0.3% | -8.3% | +2.2% | +3.0% | -4.2% | -0.8% |
| Aug 11 | Citigroup | Maintains | Neutral → Neutral | — | $1.32 | $1.30 | -1.5% | +13.6% | +4.0% | -9.0% | -0.7% | -2.8% |
| Mar 6 | Credit Suisse | Maintains | Underperform → Underperform | — | $1.09 | $1.08 | -0.9% | -11.0% | +5.1% | -4.0% | -2.4% | -4.4% |
| Mar 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $1.09 | $1.08 | -0.9% | -11.0% | +5.1% | -4.0% | -2.4% | -4.4% |
| Nov 16 | Citigroup | Maintains | Neutral → Neutral | — | $1.47 | $1.45 | -1.4% | -6.8% | -6.6% | +3.9% | -6.8% | +0.8% |
| Nov 8 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $1.36 | $1.37 | +0.7% | -5.1% | -4.7% | +13.8% | +9.3% | -3.3% |
| Aug 9 | Citigroup | Maintains | Neutral → Neutral | — | $3.40 | $2.92 | -14.1% | -17.9% | +10.0% | +1.3% | +6.1% | -1.5% |
| Aug 9 | Credit Suisse | Maintains | Underperform → Underperform | — | $3.40 | $2.92 | -14.1% | -17.9% | +10.0% | +1.3% | +6.1% | -1.5% |
| May 10 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $2.41 | $2.76 | +14.5% | -1.7% | -10.1% | +7.5% | +14.0% | -0.8% |
| Feb 25 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $2.45 | $2.40 | -2.0% | +2.9% | +7.9% | -0.4% | -1.5% | -11.6% |
| Feb 2 | Cowen & Co. | Upgrade | Underperform → Market Perform | — | $2.79 | $3.03 | +8.6% | -1.4% | -7.3% | +3.9% | -1.1% | +5.3% |
| Jan 7 | Credit Suisse | Downgrade | Neutral → Underperform | — | $3.35 | $3.31 | -1.2% | -5.7% | +1.6% | +3.1% | -4.2% | -3.2% |
| Nov 15 | Credit Suisse | Maintains | Neutral → Neutral | — | $7.16 | $7.28 | +1.7% | +5.6% | -8.2% | -7.3% | -12.8% | +2.5% |
| Jul 12 | JP Morgan | Downgrade | Neutral → Underweight | — | $9.27 | $9.15 | -1.3% | +4.4% | -8.0% | -2.6% | -4.8% | -0.7% |
| Jun 10 | BofA Securities | Downgrade | Neutral → Underperform | — | $16.92 | $18.09 | +6.9% | -15.2% | +4.8% | -2.5% | -6.1% | -6.0% |
| May 19 | Credit Suisse | Maintains | Neutral → Neutral | — | $6.97 | $6.74 | -3.3% | -1.9% | +4.2% | -2.8% | -0.1% | +1.4% |
| May 17 | BofA Securities | Downgrade | Buy → Neutral | — | $7.47 | $7.59 | +1.6% | -8.7% | +2.2% | -1.9% | +4.2% | -2.8% |
No insider trades available.
8-K · 2.02
!! High
Clover Health Investments, Corp. -- 8-K 2.02: Earnings Results
Clover Health reported Q1 2026 financial results on May 6, revealing the company's operational performance and financial condition to investors.
May 6
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Clover Health's executive leadership transition on March 30, 2026 signals potential strategic shifts in company direction, requiring investors to monitor whether replacement leadership can improve operational performance and profitability.
Apr 1
8-K · 7.01
! Medium
Clover Health Investments, Corp -- 8-K 7.01: Regulation FD Disclosure
Clover Health (CLOV) disclosed supplemental Q&A responses via Form 8-K, providing investors updated company information available on its investor relations website.
Mar 6
8-K · 7.01
! Medium
Clover Health Investments, Corp -- 8-K 7.01: Regulation FD Disclosure
Clover Health disclosed supplemental Q&A responses via 8-K filing, providing investors additional transparency on company operations and strategy through publicly available investor relations materials.
Mar 6
8-K
Clover Health Investments, Corp -- 8-K Filing
Clover Health Investments (CLOV) filed its required 8-K report on February 26, 2026, maintaining SEC compliance and transparency with investors regarding material corporate developments.
Feb 26
Data updated apr 25, 2026 1:44am
· Source: massive.com